Duke Adult Bone Marrow Transplant Program: Allogeneic Patients Learn what allogeneic medical considerations are and how to handle them.
Allogeneic Stem Cell Transplant Dr. Sergio Giralt discusses his findings that suggest age should no longer be a contraindication to allogeneic stem cell transplantation. Dr. Armand Keating, press conference moderator, comments on the implications of this study during a briefing at the annual meeting of the American Society of Hematology.
Haemonetics® Arm to Arm®, Blood Management Solutions, 2011 Do not post or circulate this video's URL without prior written permission from Haemonetics Corporation. Copyright © 2008-2011 Haemonetics Corporation. All rights reserved.
Stem Cell Surgery by an Indian Surgeon www.medical- Renowned haematologist and oncologist from India, talks about his education, fellowship and his experience in the field of stem cell transplantation and chemotherapy. He worked in US for 14 years and published many papers on the mini stem cells transplantation during his fellowship. The time he started getting raining in this field, there were a few centre and lost of research was being done on it. There are a few diseases that can't be cured by chemotherapy alone like leukemia, lymphoma, hotchkins disease. Doctors use stem cell transplantation in two cases, when either chemotherapy is not sufficient solution or disease spring up after chemotherapy. Stem cell transplantation is used to cure haemotalogy malignancies. It is of two types -- autologous and allogeneic. In autologous stem cell transplantation, the patient gets his own cells back. This is safe and comparatively less complicated procedure, whereas in allogeneic stem cell transplantation, the patient has to take cells from other individual usually from his sibling. Since this therapy is rare and expensive. Earlier, UK and USA were the only option for a medical tourist but now, he can avail of expensive surgeries like stem cell transplantation in India at reasonable rates. Please click on the link mentioned above for more information on Stem cell surgery in India.
Off to the hospital for my bone marrow transplant This video was uploaded from an Android phone.
Uisneach Trust Uisneach Trust is a proposal to establish a public umbilical cord blood bank in Ireland. Uisneach (navel as Gaeilge) is located in the centre of Ireland in Co. Westmeath at the junction of the 4 provinces and the name proposed for the cord blood trust anchored in history, already in tomorrow. Why save cord blood? Ireland is one of the few developed countries that does not have a public resource of Cord Blood stem cells for allogeneic (other persons tissue) transplantation and as a nation we can no longer continue to freeload off others when we need units for our own. Cord Blood is an exceptional source of adult stem cells, free from ethical and moral controversy, that can save lives. Furthermore, as a new era in cell therapy and regenerative medicine dawns, Ireland needs a bank of high quality stem cells so our researchers can advance new breakthrough therapies and take their place on the world stage. Thousands of children and adults worldwide need a transplant to help save their lives. Donating cord blood to the Uisneach Trust will offer more children and adults who have not found a donor their chance of a cure. A bank of 5000 cord blood units will provide much needed transplants for people all over the world and specifically for 30-40 Irish people saving potentially 15-20 lives every year!! Collecting, processing and storing cord blood stem cells, provides valuable research samples to the medical & scientific development on transplantation, cell therapy and regenerative ...
ASH: Variable Vaccine Response in Stem Cell Recipients NEW ORLEANS -- Immunization after allogeneic hematopoietic stem cell transplantation leads to variable responses that leave many children susceptible to some diseases targeted by common vaccines, according to a study of response to reimmunization. Five years after reimmunization, more than 90% of patients had positive antibody titers to poliovirus, tet***, rubella, and the combined diphtheria-tet***-pertussis (DTaP) vaccine, researchers reported here at the annual meeting of the American Society of Hematology.
CureXcell of MacroCure, video produced by Virtual Point Movie for MacroCure - Mechanism of Action MacroCure has developed CureXcell™, a cell based therapy for hard to heal wounds, to restore the wound healing process. CureXcell™ is a cell suspension containing a white blood cell mixture that, when applied to the wound, restores the natural balance required for the wound healing process to initiate. The white blood cells are derived from a whole blood unit taken from healthy young (18-40 yrs old) donors (allogeneic), are activated by a safe, proprietary technique, and are subsequently applied locally to the wound. In this way, physiological cell activities, growth factor and cytokine secretions, and regulatory mechanisms are maintained as required during each of the stages of wound healing. Clinical trials in Israel have shown a 90% reduction of mortality in patients with deep sternal wound infections post open heart surgery and a markedly improved healing rate for severe pressure ulcers. Since the introduction of CureXcell™ to the market, more than 4000 patients have been treated in Israel without any significant side effects. 3D video animation produced by Virtual Point
Autologous Blood and Marrow Transplant at Mayo Clinic 6 Autologous Blood and Marrow Transplant at Mayo Clinic part 6: Coping with a Transplant
ASH 2010: The use of maintenance treatments in myeloma patients Prof Antonio Palumbo, Molinette Hospital, Turin, Italy, and Prof Vincent Rajkumar, Mayo Clinic, Arizona, USA, discuss some of the key research into myeloma that was presented at ASH 2010. This includes trials demonstrating that post transplant lenalidomide maintenance treatment dramatically improves progression free survival, a study comparing bortezomib (Velcade) with thalidomide as maintenance treatments, a trial investigating the use of pomalidomide in patients refractory to both bortezomib and lenalidomide, research into the use of bisphosphonates and a trial showing the drawbacks of allogeneic stem cell transplants. Prof Antonio Palumbo speaks about the research he presented which highlights the benefits of drug combinations followed by lenalidomide or bortezomib and thalidomide maintenance treatments. These trials have produced extremely positive complete response rates in patients aged 65-75, offering clinicians with an alternative to stem cell transplants.
***ALERT*** ARE THERE CHIMERA's IN THE GULF??? My video on ARE THE EELS DNA BEING CHANGED??? MaximusRising commented the following: One of the marine biologists answered me, saying he thinks it's a chimera. I think he's correct. Defination:Chimeras are formed from four parent cells (two fertilized eggs or early embryos fused together). Each population of cells keeps its own character and the resulting animal is a mixture of tissues. This condition is either inherited, or it is acquired through the infusion of allogeneic hematopoietic cells during transplantation or transfusion. In nonidentical twins, chimerism occurs by means of blood-vessel anastomoses. The likelihood of offspring being a chimera is increased if it is created via in vitro fertilization. Chimeras can often breed, but the fertility and type of offspring depends on which cell line gave rise to the ovaries or testes; varying degrees of inter***uality may result if one set of cells is genetically female and another genetically male.
Bone Marrow Transplant "I was just very, very thankful for some good doctors and a whole lot of prayers going up on my behalf." -- Matthew Bogard, 32, Parkersburg, W.Va. Struggling with the sudden onset of fatigue and pneumonia, Matthew was diagnosed with Hodgkin's lymphoma and leukemia. A few months later, he underwent a successful bone marrow transplant. Thankful for renewed energy, Matthew is teaching classes at a local Christian college and pursuing an information technology career.
The Miracle of Birth Converting Placental-derived Adult Stem Cells to Therapeutics Pluristem Therapeutic Inc. (NasdaqCM: PSTI) is a bio-therapeutics company dedicated to the commercialization of allogeneic (non-personalized) cell therapy products derived from the human placenta, an organ that has traditionally been considered medical waste after childbirth. The company uses its PLX products for the treatment of a variety of ischemic and autoimmune disorders where current therapies are unavailable or inadequate. Pluristem's adherent stromal cells are and a non-embryonic, non-controversial source of cells.
News Update: CryoLife Rises on FDA Clearance for Human Cardiac Patch CryoLife Inc (CRY) is on the rise before the bell as the cardiovascular tissue processing company received 510(k) FDA clearance for a five-year shelf life on its CryoPatch SG pulmonary human cardiac patch. The technology is designed to remove allogeneic donor cells and cellular remnants from tissue without compromising the underlying collagen matrix. Shares in the Kennesaw, Georgia-based company have traded between $4.80 and $8.87 over the past 12 months.
In between stem cell transplants recovering from an auto stem cell transplant, getting ready for the donor transplant. 5 weeks since first transplant, will repeat bone marrow biopsy on Jan 19.
Pluristem on the Israeli "Channel 1" Mr. Zami Aberman, Pluristem's CEO interview for the Israeli "Channel 1"
Brooke after 2nd stem cell transplant 9/3 Brooke dancing to a song that was written just for her by Songs of Love.
Hematopoietic stem cell transplantation #2 Bone Marrow Transplantation (or Hematopoietic Stem Cell Transplantation) This modern procedure is the only accepted method worldwide to cure beta-thalassemia diseases. The patients will need to have suitable HLA-matched healthy donors, possibly their own brothers / sisters or unrelated volunteers. We will test the patients blood, as well as potential donors, for the typing and matching and cooperate in circumstance of searching for appropriate unrelated donor is needed. Sources of donors stem cells may be achieved from bone marrow, peripheral blood, or umbilical cord blood. Allogeneic bone marrow transplantation is sophisticated scheme of therapy and integration of medical sciences and technology. We offer this well-organized comprehensive treatment programs for particular group of patients who have full-filled indication for undergoing transplantations. Our hematologist will discuss, explain and answer you in details regarding this effective and informed curative therapy.
Countdown to Bone Marrow Transplant: 2 Weeks Dealing with nervousness and worry about upcoming allogeneic stem cell transplant. There are real dangers to this treatment, so I'm scared out of my wits, but determined to be successful.
Mismatched Cord Blood Dr. Mary Eapen reports findings that mismatched umbilical cord blood is as effective as mismatched bone marrow or peripheral blood in allogeneic stem cell transplantation in adults with acute leukemia.
Stem Cell Transplant Recovery Hits Snag: The Common Cold I think the title says it all. This is just an update as to how my recovery is going following an autologus stem cell transplant for multiple myeloma.
BMT Program at Alta Bates Summit Medical Center In many cases Bone Marrow Treatment (BMT) is a life-saving treatment option for patients with a diagnosis of leukemia, Hodgkin's or non- Hodgkin's lymphoma and multiple myeloma, as well as other cancer malignancies and blood disorders. With recent technological advances BMT has become an effective, proven first-line treatment choice by oncologists. The first BMT program to be offered in the Northern California area was pioneered by the Alta Bates Summit Medical Center in 1984. Over the years over 550 bone marrow transplantations (including both allogeneic and autologous transplants) have been performed by the highly-experienced and medically innovative Alta Bates Summit medical team. Today, the BMT program at Alta Bates Summit Medical Center continues to lead the way in pioneering better options for its cancer patients.
Allogeneic Stem Cell Transplant: Dealing with the risks with my support system This is my opportunity to thank you all for your support. I have an amazing support system; whether it's my YouTube subscribers, family or friends. I'm going to need all the help I can get going into this bone marrow transplant (stem cells from a donor).
Stem Cells Research at Hadassah Hadassah hospital in Israel is one of the leading hospitals in the world. Hadassah's Bone Marrow Transplantation Center (BMT) and Cancer Immunotherapy and Cell Therapy Research Center is lead by Prof. Reuven Or. The center offers various types of treatments including autologous and allogeneic stem cells transplantation using various types of donors, with bone marrow, blood, and cord blood used as sources of stem cells. The treatments are performed in the serenity environment of Jerusalem and are offered at moderate prices. Request for information at: .il